Effects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infection

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 9, 2005, Pages 3868-3874

  Song, Zhijun ^a,c   Wu, Hong ^a   Mygind, Per ^b   Raventos, Dora ^b   Sonksen, Garsten ^b   Kristensen, Hans Henrik ^b   Høiby, Niels ^a  

^a University Hospital of Copenhagen ^*  (Denmark)

^b NOVOZYMES A S   (Denmark)

^c International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; CYTOKINE; NOVISPIRIN G10; OCTAPEPTIDE; SHEEP MYELOID ANTIMICROBIAL PEPTIDE 29; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIOFILM; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; IMMUNE RESPONSE; LUNG INFECTION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RAT; TREATMENT OUTCOME;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CLONING, MOLECULAR; COLONY COUNT, MICROBIAL; CYSTIC FIBROSIS; CYTOKINES; ESCHERICHIA COLI; FEMALE; INTUBATION, INTRATRACHEAL; LUNG; LUNG DISEASES; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RATS; RATS, INBRED LEW; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 24144451769     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.9.3868-3874.2005     Document Type: Article

References (34)

1. Agnihotri, N., V. Gupta, and R. M. Joshi. 2004. Aerobic bacterial isolates from burn wound infections and their antibiograms - a five-year study. Burns 30:241-243.
2. Babcock, H. M., J. E. Zack, T. Garrison, E. Trovillion, M. H. Kollef, and V. J. Fraser. 2003. Ventilator-associated pneumonia in a multi-hospital system: differences in microbiology by location. Infect. Control Hosp. Epidemiol. 24:853-858.
3. Bagge, N., M. Schuster, M. Hentzer, O. Ciofu, M. Givskov, E. P. Greenberg, and N. Høiby. 2004. Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and β-lactamase and alginate production. Antimicrob. Agents Chemother. 48:1175-1187.
4. Bartlett, K. H., P. B. McCray, Jr., and P. S. Thorne. 2003. Novispirin G10-induced lung toxicity in a Klebsiella pneumoniae infection model. Anti-microb. Agents Chemother. 47:3901-3906.
5. Conway, S. P., K. G. Brownlee, M. Denton, and D. G. Peckham. 2003. Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis. Am. J. Respir. Med. 2:321-332.
6. Drenkard, E. 2003. Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect. 5:1213-1219.
7. Gavit, P., and M. Better. 2000. Production of antifungal recombinant peptides in Escherichia coli. J. Biotechnol. 79:127-136.
8. Govan, J. R., and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonus aureginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
9. Hentzer, M., H. Wu, J. B. Andersen, K. Riedel, T. B. Rasmussen, N. Bagge, N. Kumar, M. A. Schembri, Z. Song, P. Kristoffersen, M. Manefleld, J. W. Costerton, S. Molin, L. Eberl, P. Steinberg, S. Kjelleberg, N. Høiby, and M. Givskov. 2003. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J. 22:3803-3815.
10. Hoffmann, N., T. B. Rasmussen, P. Jensen, C. Stub, M. Hentzer, S. Molin, O. Ciofu, M. Givskov, H. K. Johansen, and N. Høiby. 2005. A novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis. Infect. Immun. 73:2504-2514.
11. Høiby, N., and B. Frederiksen. 2000. Microbiology of cystic fibrosis, p. 83-107. In M. E. Hudson and D. M. Geddes (ed.), Cystic fibrosis. Arnold, London, United Kingdom.
12. Høiby, N., J. H. Krogh, C. Moser, Z. Song, O. Ciofu, and A. Kharazmi. 2001. Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth. Microbes Infect. 3:23-35.
13. Jauregui-Adell, J., and J. Marti. 1975. Acidic cleavage of the aspartyl-proline band and the limitations of the reaction. Anal. Biochem. 69:468-473.
14. Johansen, H. K., F. Espersen, S. J. Cryz, Jr., H. P. Hougen, A. Fomsgaard, J. Rygaard, and N. Høiby. 1994. Immunization with Pseudomonas aeruginosa vaccines and adjuvant can modulate the type of inflammatory response subsequent to infection. Infect. Immun. 62:3146-3155.
15. Kalfa, V. C., H. P. Jia, R. A. Kunkle, P. B. McCray, Jr., B. F. Tack, and K. A. Brogden. 2001. Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells. Antimicrob. Agents Chemother. 45:3256-3261.
16. Lehrer, R. I., and T. Ganz. 1996. Endogenous vertebrate antibiotics. Defensins, protegrins, and other cysteine-rich antimicrobial peptides. Ann. N. Y. Acad. Sci. 797:228-239.
17. Lehrer, R. I., M. Rosenman, S. S. Harwig, R. Jackson, and P. Eisenhauer. 1991. Ultrasensitive assays for endogenous antimicrobial polypeptides. J. Immunol. Methods 137:167-173.
18. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
19. Sawai, M. V., A. J. Waring, W. R. Kearney, P. B. McCray, Jr., W. R. Forsyth, R. I. Lehrer, and B. F. Tack. 2002. Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides. Protein Eng. 15:225-232.
20. Sekiya, H., T. Mima, Y. Morita, T. Kuroda, T. Mizushima, and T. Tsuchiya. 2003. Functional cloning and characterization of a multidrug efflux pump, MexHI-OpmD, from a Pseudomonas aeruginosa mutant. Antimicrob. Agents Chemother. 47:2990-2992.
21. Skerlavaj, B., M. Benincasa, A. Risso, M. Zanetti, and R. Gennaro. 1999. SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes. FEBS Lett. 463:58-62.
22. Song, Z., H. K. Johansen, V. Faber, C. Moser, A. Kharazmi, J. Rygaard, and N. Høiby. 1997. Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats. Antimicrob. Agents Chemother. 41:961-964.
23. Song, Z., H. K. Johansen, C. Moser, and N. Høiby. 1996. Effects of Chinese medicinal herbs on a rat model of chronic Pseudomonas aeruginosa lung infection. APMIS 104:350-354.
24. Song, Z., A. Kharazmi, H. Wu, V. Faber, C. Moser, H. K. Krogh, J. Rygaard, and N. Høiby. 1998. Effects of ginseng treatment on neutrophil chemiluminescence and immunoglobulin G subclasses in a rat model of chronic Pseudomonas aeruginosa pneumonia. Clin. Diagn. Lab. Immunol. 5:882-887.
25. Song, Z., H. Wu, K. Mathee, N. Høiby, and A. Kharazmi. 2002. Gerimax ginseng regulates both humoral and cellular immunity during chronic Pseudomonas aeruginosa lung infection. J. Altern. Complement Med. 8:459-466.
26. Song, Z. J., H. K. Johansen, V. Faber, and N. Høiby. 1997. Ginseng treatment enhances bacterial clearance and decreases lung pathology in athymic rats with chronic P. aeruginosa pneumonia. APMIS 105:438-444.
27. Song, Z. J., H. K. Johansen, C. Moser, V. Faber, A. Kharazmi, J. Rygaard, and N. Høiby. 2000. Effects of Radix angelicae sinensis and shuanghuanglian on a rat model of chronic Pseudomonas aeruginosa pneumonia. Chin. Med. Sci. J. 15:83-88.
28. Steinstraesser, L., B. F. Tack, A. J. Waring, T. Hong, L. M. Boo, M. H. Fan, D. I. Remick, G. L. Su, R. I. Lehrer, and S. C. Wang. 2002. Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns. Antimicrob. Agents Chemother. 46:1837-1844.
29. Stover, C. K., X. Q. Pham, A. L. Erwin, S. D. Mizoguchi, P. Warrener, M. J. Mickey, F. S. Brinkman, W. O. Hufnagle, D. J. Kowalik, M. Lagrou, R. L. Garber, L. Goltry, E. Tolentino, S. Westbrock-Wadman, Y. Yuan, L. L. Brody, S. N. Coulter, K. R. Folger, A. Kas, K. Larbig, R. Lim, K. Smith, D. Spencer, G. K. Wong, Z. Wu, I. T. Paulsen, J. Reizer, M. H. Saier, R. E. Hancock, S. Lory, and M. V. Olson. 2000. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406:959-964.
30. Svendsen, L, and K. Breddam. 1992. Isolation and amino acid sequence of a glutamic acid specific endopeptidase from Bacillus licheniformis. Eur. J. Biochem. 204:165-171.
31. Tredget, E. E., H. A. Shankowsky, R. Rennie, R. E. Burrell, and S. Logsetty. 2004. Pseudomonas infections in the thermally injured patient. Burns 30:3-26.
32. Wu, H., Z. Song, M. Givskov, G. Doring, D. Worlitzsch, K. Mathee, J. Rygaard, and N. Høiby. 2001. Pseudomonas aeruginosa mutations in lasI and rhll quorum sensing systems result in milder chronic lung infection. Microbiology 147:1105-1113.
33. Wu, H., Z. Song, M. Hentzer, J. B. Andersen, S. Molin, M. Givskov, and N. Høiby. 2004. Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice. J. Antimicrob. Chemother. 53:1054-1061.
34. Yasin, B., M. Pang, R. I. Lehrer, and E. A. Wagar. 2003. Activity of novispirin G-10, a novel antimicrobial peptide against Chlamydia trachomatis and vaginosis-associated bacteria. Exp. Mol. Pathol. 74:190-195.